Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination
Wang‐Huei Sheng(National Taiwan University Hospital), Sui‐Yuan Chang(National Taiwan University of Science and Technology), Pin‐Hung Lin(National Taiwan University), Shu‐Hsing Cheng(Ministry of Health and Welfare), Chien‐Yu Cheng(Tao Yuan General Hospital), Si‐Man Ieong(National Taiwan University), Ming‐Ju Hsieh(National Taiwan University Hospital), Ching‐Fu Pan(National Taiwan University), Hao Chang(Qingdao University), Tai‐Ling Chao(National Taiwan University), Hung‐Chih Yang(Johns Hopkins University), Jang-Pin Chen(Ministry of Health and Welfare)
Cited by 28
Related Papers
Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
|Immunity|2012|707
Processing of the initiation methionine from proteins: properties of the Escherichia coli methionine aminopeptidase and its gene structure
|Journal of Bacteriology|1987|512
Cellular immune selection with hepatitis C virus persistence in humans
|The Journal of Experimental Medicine|2005|304
Prolonged virus shedding even after seroconversion in a patient with COVID-19
|Journal of Infection|2020|302